Autologous Chondrocyte Implantation or Transplantation - Medical Policy
Customize your policy alerts
Sign up for Health-New-England Policy UM256POL alerts
Get alerted when Policy UM256POL changes without checking for updates manually.
Monitor payer policy activity
Prior authorization and medical-necessity review for autologous chondrocyte implantation or transplantation across Commercial, Medicare Advantage, and Medicaid (BeHealthy) lines of business. Approval applies to knee procedures meeting applicable InterQual criteria; other joints or indications are considered experimental and investigational.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.